Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$88.62 -1.58 (-1.75%)
At close: Oct 21, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Short term Debt (2024 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) reported Short term Debt of $12.7 million for Q2 2026, up 236.2% from $3.78 million a year earlier and up 25.4% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Short term Debt (2024 - 2026) Analysis & Trends

At the end of FY2025, Rhythm Pharmaceuticals posted Short term Debt of $7.3 million, up 373.5% from FY2024.

  • By year, Short term Debt came in at $1.54 million in FY2024.
  • Year over year, Short term Debt has now increased in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $10.13 million (Q1 2026), $7.3 million (Q4 2025) and $5.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Rhythm Pharmaceuticals 6.07 Bn 4.94 Bn 62.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.70 Mn
Mar 31, 2026 10.13 Mn
Dec 31, 2025 7.30 Mn
Sep 30, 2025 5.56 Mn
Jun 30, 2025 3.78 Mn
Mar 31, 2025 1.59 Mn
Dec 31, 2024 1.54 Mn
API Access

Rhythm Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=RYTM&period=max&api_key=YOUR_API_KEY